Eli Lilly’s GLP-1 medicines created DKK 231bn in sales in 2014, DKK 3bn greater than Novo Nordisk’s leading medication in the exact same classification.
发布者:BY Christopher Karlsson,转转请注明出处:https://robotalks.cn/eli-lilly-surpassed-novo-nordisk-in-key-glp-1-market-in-2025/